Amber Perry
Family · Indianapolis, INNPI 1922535251
Payments from drug & device makers
Across 99 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$383
- Lilly USA, LLC$166
- Axsome Therapeutics, Inc.$91
- Seqirus USA Inc$75
- Amgen$72
- GSK$70
- plus $940 from 28 others
What the payments were for
- Food & beverage$1,68194%
- Education$1166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $383 |
| Lilly USA, LLC | 10 | $166 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Seqirus USA Inc | 3 | $75 |
| Amgen | 5 | $72 |
| GSK | 5 | $70 |
| Novartis | 4 | $68 |
| Supernus Pharmaceuticals, Inc. | 4 | $68 |
| Exact Sciences | 3 | $66 |
| Verona Pharma, Inc. | 3 | $65 |
| Merck | 4 | $63 |
| AbbVie | 2 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Pfizer | 3 | $44 |
| Boehringer Ingelheim | 3 | $43 |
| Sanofi Pasteur Inc. | 2 | $38 |
| Corium, LLC | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Cranial Technologies, Inc | 2 | $31 |
| AstraZeneca | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Axonics, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Indivior Inc. | 1 | $15 |
| Viiv Healthcare Company | 1 | $14 |
| Mylan Specialty L.p. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$116
How this compares
$1,797 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 28 | $31,801 |
| FarxigaDapagliflozin Propanediol | 34 | $30,840 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $20,093 |
| Bydureon BciseExenatide Microspheres | 13 | $17,096 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $11,532 |
| Spiriva RespimatTiotropium Bromide | 17 | $8,814 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $4,682 |
| Ventolin HfaAlbuterol Sulfate | 11 | $906 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $804 |
| Atorvastatin Calcium | 148 | $713 |
| Omeprazole | 40 | $564 |
| Buspirone Hcl | 36 | $511 |
| Celecoxib | 12 | $455 |
| Verapamil SrVerapamil Hcl | 13 | $452 |
| Gabapentin | 41 | $428 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $30 | $42,37146 claims |
| Lilly USA, LLCMounjaro | $166 | $31,80128 claims |
| GSKTrelegy Ellipta | $70 | $20,09321 claims |
| Boehringer IngelheimSpiriva Respimat | $43 | $8,81417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,392 family providers in Indiana.
Other family in Indianapolis
- Tina SizemoreIndianapolis$888K
- Marla MosesIndianapolis$142K
- Leslye FisherIndianapolis$73K
- Alicia WettrickIndianapolis$72K
- Christine BaltIndianapolis$30K
- Kathryn KennedyIndianapolis$29K
- Andrea RandallIndianapolis$27K
- Deidre ArmsIndianapolis$26K
- Carrie GravesIndianapolis$16K
- Dominique LevequeIndianapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.